Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_assertion type Assertion NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_head.
- NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_assertion description "[We measured the cytokine levels of Th1 (IL-2 and IL-2R), Th2 (IL-10) and the pro-inflammatory cytokines (IL-6 and IL-6R and TNF and TNF-RI and II) by the ELISA technique in the sera of 33 hepatocellular carcinoma (HCC) patients and 20 chronic liver disease (CLD) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_provenance.
- NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_assertion evidence source_evidence_literature NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_provenance.
- NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_assertion SIO_000772 16425355 NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_provenance.
- NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_assertion wasDerivedFrom befree-20150227 NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_provenance.
- NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_assertion wasGeneratedBy ECO_0000203 NP504692.RAPZLK1_HVMY6Q7bserIv3xT8fwcblazkqJTR1IRr36cE130_provenance.